Diabetes is one of the most common long-term health conditions in the world. It affects hundreds of millions of people and happens when the body cannot properly control the amount of sugar, also called glucose, in the blood.
Over time, high blood sugar can damage blood vessels, nerves, the heart, the kidneys, and the eyes. Because of this, keeping blood sugar under control is very important for people living with diabetes.
Doctors often recommend a combination of healthy eating, regular physical activity, weight management, and medication to help control the condition. In recent years, a medicine called semaglutide has attracted a lot of attention because it can help lower blood sugar while also helping people lose weight.
Weight loss is especially important because many people with type 2 diabetes are overweight or obese, and losing weight can improve blood sugar control and reduce the risk of serious health problems.
A new international study led by Dr. John Buse examined whether larger doses of semaglutide could provide greater benefits than the dose that is already commonly used. The findings were published in The Lancet, one of the world’s leading medical journals.
The research involved 1,606 adults with type 2 diabetes. Most participants were men, and the average age was about 58 years. At the beginning of the study, their diabetes was not well controlled.
Their A1C levels ranged from 8.0% to 10.5%. A1C is a blood test that shows average blood sugar levels over the previous two to three months. For many adults with diabetes, doctors aim for an A1C level below 7% because this can lower the risk of long-term complications.
The participants were divided into three groups. One group took 14 milligrams of semaglutide each day, another group took 25 milligrams, and the third group took 50 milligrams. The treatment continued for one year, allowing researchers to compare how well each dose worked over time.
The results showed clear differences between the groups. People who received the higher doses generally achieved better blood sugar control than those taking the lower dose. By the end of the study, participants taking 25 milligrams or 50 milligrams were more likely to reduce their A1C levels to below 7%, indicating much better management of their diabetes.
The higher doses also produced greater weight loss. Semaglutide works partly by reducing appetite and helping people feel full sooner when eating. This can lead to lower food intake and gradual weight reduction.
After one year of treatment, people taking the 50-milligram dose lost an average of about 17.5 pounds. Those taking the 25-milligram dose lost around 14.8 pounds. In comparison, participants taking the 14-milligram dose lost about 10 pounds.
According to Dr. Buse, the standard dose already does a good job of lowering blood sugar. However, increasing the dose appears to provide extra benefits, particularly when it comes to weight loss.
This may be important because excess body weight can make diabetes harder to manage and can increase the risk of other health conditions, including heart disease.
Like most medicines, semaglutide can cause side effects. The most common problems reported in the study involved the digestive system. Some participants experienced nausea, which is the feeling of wanting to vomit.
Others reported diarrhea or constipation. These side effects were generally more common among people taking the larger doses. Even so, the researchers found that the overall safety profile of the medicine was similar to what had been seen in earlier studies.
The findings suggest that higher-dose semaglutide may offer a useful option for people who need stronger blood sugar control or who would benefit from greater weight loss. However, treatment decisions should always be made with the guidance of a healthcare professional, who can consider a person’s medical history, health goals, and potential side effects.
As diabetes continues to affect more people worldwide, researchers are looking for better ways to help patients manage the condition and prevent complications. This study adds to growing evidence that semaglutide can play an important role in diabetes care.
While larger doses may not be right for everyone, they appear to offer additional benefits for many patients when carefully prescribed and monitored by doctors.
If you care about diabetes, please read studies about 5 vitamins that may prevent complication in diabetes, and how to manage high blood pressure and diabetes with healthy foods.
For more health information, please see recent studies about vitamin D and type2 diabetes, and to people with type 2 diabetes, some fruits are better than others.
Copyright © 2026 Knowridge Science Report. All rights reserved.
